Zoetis reported $582M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.84B 205M Sep/2026
Align Technology USD 410.55M 52.12M Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Bristol-Myers Squibb USD 1.7B 127M Sep/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Dentsply International USD 363M 1000K Sep/2026
Eli Lilly USD 3.12B 305M Sep/2026
Henry Schein USD 819M 12M Sep/2026
Idexx Laboratories USD 293.13M 5.04M Sep/2026
Illumina USD 281M 8M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Laboratory Of America USD 611.4M 34.2M Sep/2026
Merck USD 2.86B 25M Sep/2026
Neogen USD 100.8M 1000K Jun/2026
Pacira USD 950.8M 858.99M Sep/2026
Perrigo USD 271.7M 3.01B Sep/2026
Pfizer USD 3.28B 132M Sep/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Quest Diagnostics USD 523M 6M Sep/2026
Sanofi EUR 2.31B 325M Sep/2026
Sanofi EUR 2.63B 140M Jun/2026
Zoetis USD 582M 10M Sep/2026